Drug Overdose Deaths Have Surged During the Pandemic, C.D.C. Says
The latest numbers surpass even the yearly tolls during the height of the opioid epidemic and mark a reversal of progress against addiction in recent years.
"As pharmacists we have had to think outside the box in many ways during COVID-19, whether it is finding ways to do work remotely, curbside delivery, or dealing with COVID-related medication shortages."
Millions of Medicaid enrollees risk losing their coverage when the COVID-19 public health emergency ends. What can be done to minimize this risk?
The objective of this review was to analyze the existing data on acute inflammatory myelopathies associated with coronavirus disease 2019 infection, which were reported globally in 2020. PubMed, CENTRAL, MEDLINE, and online publication databases were searched. Thirty-three acute inflammatory myelopathy cases (among them, seven cases had associated brain lesions) associated with coronavirus disease 2019 infection were reported. Demyelinating change was seen in cervical and thoracic regions (27.3% each, separately). Simultaneous involvement of both regions, cervical and thoracic, was seen in 45.4% of the patients. Most acute...
Provided no new variant emerges, former FDA chief Dr Scott Gottlieb, predicted Covid will become an endemic disease, meaning always present but transmitting at low rates.
Scientific advisers to the C.D.C. also recommended the coronavirus vaccine boosters for those with certain medical conditions, but excluded those at risk because of their jobs.
The U.S. vaccination drive against COVID-19 is poised for a major new phase: Government advisers on Thursday recommended booster doses of Pfizer’s vaccine for millions of Americans
During the Covid-19 pandemic, the existing overdose epidemic has only continued to rise. So have the rates of substance use. Addiction experts, including the head of the National Institute on Drug Abuse, weigh in on what this data means and what else we should be considering.
Conclusions: These findings may provide insight into changes in opioid overdose mortality during this time and assist in future disaster planning.
In 1974, President Nixon signed the Narcotic Addiction Treatment Act, which gave statutory authority to the regulations governing the provision of methadone for the treatment of opioid use disorder (OUD) in the US. The original name for the bill was revealing: the Methadone Diversion Control Act. These regulations that were meant to restrict dispensation on methadone have undergone only modest revision over the ensuing decades even in the midst of a current overdose epidemic. In the US, methadone for OUD can only be provisioned at federally certified opioid treatment programs (OTPs). Patients receiving methadone must prese...